Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Cheers Dil!

THE COUNT--->DIL

You and I have not seen eye to eye on a few things recently.

But I am going to try and redress this a little. I hate to tip a share outright....I usually just post about what I am doing and why I am doing it, and where I think a share could be going in the medium term, and then leave it to people to make their own decisions accordingly.

But I think this story is awesome and I believe, in the absence of the expected announcement about a further deal, and all this talk of further fund raising (can only be seen in a positive light), that we are going to have a spectacular fireworks display for the results day....assuming we don't get any further announcements before the results.

DIL, I think you should tuck a few of these away for a year or two (even at these prices)....you will not be disappointed I'm sure. Now, before anyone else follows my advice, that is only meant for DIL. I only want one person trying to sue me if my advice goes wrong!!!!

If you guys want to knock other stocks with no real substance yet (or that may have run a liitle ahead of reality), then why don't you look at TRK, PRM, GHT, TDM and, dare I say it KTS (nah, only kidding about that last one)?

I might just get to make it on your Christmas card list with that tip.

All IMHO of course.

THE COUNT!

The Count -
just wanted to say that I (and I'm sure lots of other people) really appreciate your posts over here at moneyam and PLEASE would you post here each time you post on advfn - it has become impossible to keep abreast on the 600+ a day advfn posts
regards
Anna

TARGETS:
Expect 1.80-2.00 by next w/e if no news
Expect 2+ if OTC deal announced
Expect 1.70 if plcing is announced (IMO this would have to be accompanied by a relevant PR related to the OTC deal)

This IS without question the most exciting stock on today's market.

The blue touch paper is about to be lit.
I'm also..... "expecting the unexpected."

Though I think next Friday there may be a huge load of buys prior to results on Monday.

The above figs based on what people have said on various boards and my own limited research.

Regards Nematode.

Thanks nematode I just give an honest opinion and get told to piss off. Posters like you give bulletin boards a bad name.

No mate,if you are not interested in BPRG then why hang around with negative posts which add nothing to the value of this thread,however if you've got something to say from your time spent researching the company then you are more than welcome to do so.

I am interested in BPRG, otherwise I wouldn't bother reading this thread. imop the price went up far too quickly and when it fell like a stone a lot of punters got their fingers burnt. I was thinking of buying back in but I'm not convinced that now is the right time for various reasons, the situation with Stanelco being one. Also I think if you have, in your own words, done " limited research " you shouldn't make assertions like " the blue touch paper is about to be lit", and " this is without question the most exciting stock in today's market". I do agree with you that there may be a lot of buying before the results on the 8th, but how the market reacts to these results is anyone's guess.

Bioprogress plans placing at 100p
Tim Freeborn
Announcement likely next week; placing at very deep discount

BioProgress Technology Internatinal(BPRG), the current punters favourite, is planning a placing next week at 100p. One investor was told he had to pay by next Wednesday.

In December the company raised 7m at 50p to fund the building of a factory to make its patented Xgel film.

The new placing is likely to coincide with a deal with a US maker of non-prescription medicines. This was promised by the end of January but has apparently been delayed because BioProgress concentrated on the link-up with FMC Biopolymer which was announced on 4 February and sent the shares soaring.

BioProgress has made a habit of raising money at a deep discount. It was floated early last year at 14p, around a third below its price on the Nasdaq OTC market. The December placing was also a third below its then price.

Late morning Bioprogress shares were down 3.9% to 132.5p. The company plans to post its preliminary results for the trading period from 22 May 2003 to 31 December 2003 on Monday 8 March.

Goldfinger - Good call on 04-02-04 you have inside info;?
Results 08-03-04, where do you see BPRG by mid year? tia...

Cheers Count , I'll drop you a line next week but in the mean time my tip for you is .... Arsenal for the league :-)

THE COUNT--->DIL

Some bloody tip.

I think I'm going to throw up now that you've mentioned it. Who can catch them now?

THE COUNT!

Hi chartist2004, I never like to give or set price targets, thats up to the market. One as to ask though if this news from Tim Freeborn is correct what is the new money needed for???????.

A, they are running out of working capital since the rights issue before Xmas,

B, they are working together with a large US company in partnership on some further big capital project,

C, they feel they need to refinance the balance sheet before a whole raft of deals after the results

D, It maybe a combination of all three above

Perhaps the line where Tim says one investor was told he needed to pay the money before wednesday is the big give away, surely this means news will be forthcoming not wether, but that the deal as been done and that the news will be out in the Public Domain by at least Wednesday.

Personaly for myself, the sooner the better, as all this speculation doesnt do much for the blood pressure. Having a look on our competitors site one can only describe it as a nuthouse.

I still feel very confident and have indeed heard news that there is no need for panic, not that I ever did feel need to panic.

Some have called it a leaky stock on here, but come on lets face it the leaks are coming from punters, and not investors or the management.

Good luck to all.

cheers GF.

GF. thanks for the reply, was thinking of bagging a few but I'll take a rain check for now and watch how thing span out next week.

Hi chartist2004 hope my post didnt come over as negative as it wasnt meant to be. Im very positive on this one, just think theres too much silly hype sorrounding it at the moment, both ways.

cheers GF.

THE COUNT--->GOLDFINGER

Isn't there silly hype on just about every thread of any stock that begins to attract hot attention?

Do you let muppets who don't even know what the company does scare you from your own belief of where the stock may or may not be heading?

When I read some of the crap on the various BBs, I wonder whether some of those idiots should be banned from investing their own money for their own protection. But such is life.

THE COUNT!

GF is one of the main sources of the silly hype aren't you GF ?

From Lemmings...


Bioprogress, A classic tree shake, or are investors simply activating their
stop-losses, or could there be a sea change in sentiment? Well, this lemming activated his stop-loss yesterday.just as well as another 16.5% is wiped off, down from a high of 164p to 122p. I may have the chance to buy back in at 110/115p before events turn for the better. Who knows, I may end up ruing my strategy. All in the timing as they say.

One broker known to lemming cites that mm`s are manipulating the share price ahead of what is expected to be a significant news item which is expected within days. Probably on the March 8. The same source says that mm`s are short of stock.

This is a classic way of ruffling a few feathers in winter forcing those with few feathers left to sell the nest egg for a winter warmer. This may or may not be accurate analysis of the past 3 days trades, but one has to wonder what will happen once the assumed announcement is as expect, announced. Would the mm`s have you chase up and over the 164pprobably!




I don't think that enough weight has been given to the enormity of the two FMC undertakings to spend at least $80m with BPRG in each case. Where else, or how often do we see contracts of that magnitude? Certainly not in the AIM or Small Cap sector. Only the capital equipment stocks in the Footsie 100, and construction , property, and resource stocks in the FT250, report deals of that size.

NXT, Imagination, Skyepharma, ARM, Autonomy, Xaar, Torotrak and Antonov, Oystertec, Aerobox, are only a few of the many IP companies which have recently closed well received contracts with global firms, and whose shares have since been rising, in some cases swiftly. For security reasons, most of these agreements have no value ascribed to them, or if they do, consist of 1-2m down payments or less, and tiny royalties which might earn 1-2m/pa, and even that not for three years.

The "at least $160m" , FMC contract is big enough to imply that BPRG is a FT 250-stock-in-the-making at the very least. FMC would not have committed to such a large deal if BPRG had looked like remaining a small time company with small-time directors remaining a Small Cap stock - let alone an AIM stock, And the lowest Footsie 250 stocks have a cap value of around 300m except for two or three which have fallen further and will probably be relegated. This corresponds to roughly 2.95 for a share in BPRG. The middle of the FT250 is inhabited by caps of around 600m equivalent to a share price of 5.90

From Edward Kalfayan(Lemmings)

Interesting post from geoffarnold over on ADVFN, perhaps might explain why BPRG might want to raise funds? Also remember a reported comment from Graham Hind recently to the effect that good liquidity in BPRG stock meant that he might consider acquisitions....

"Were the contents of the following pages supplied by the same person?
Or plagiarised? Identical photographs and identical text, (in places)

Aquafilm, quite literally has Bioprogress written all over it.

http://www.aquafilm.com/html/products/Pharma.html
http://www.bioprogress.com/html/products/non_ingestible.html

Edit:
for example,

From Aquafilm page:
What is the source of gelatin? IT IS derived from ANIMAL BY-PRODUCTS,
PRIMARILY BONES AND HIDES of CATTLE AND PIGS. THIS IS UNACCEPTABLE TO VEGETARIANS AND MANY ETHNIC AND RELIGIOUS GROUPS WORLDWIDE.

From Bioprogress page:
But where does gelatin come from? IT IS comprised of
ANIMAL BY-PRODUCTS, PRIMARILY BONES AND HIDES of CATTLE AND PIGS. Of course, THIS IS UNACCEPTABLE TO VEGETARIANS AND MANY ETHNIC AND RELIGIOUS GROUPS WORLDWIDE."

From the Telegraph

Which are you? A gambler or an investor?
(Filed: 29/02/2004)

A clutch of speculative shares took a knock last week - a welcome development which removes some of the froth before it begins to destabilise the market.

I shuddered at an inquiry I received that reminded me of the mania of 2000. "My friend and I, we recently bought heavily into Bioprogress near 160p, but the shares are now plunging. Can you tell me, what does this company do?"

Four years ago I heard from a punter who had bought 100,000 shares in Medi@Invest at above 100p. The price was rumoured to be heading instantly for 200p. This punter was panicking because there was no way he could settle the purchase, or afford to take a loss, but the price was 60p and falling. He too asked: "What does this company do?"

Thankfully, this kind of ignorant speculation seems to be mainly a feature of the Aim market. Bioprogress, where hopes focus on a mass-market replacement for gelatine in pills, is starting to sign licensing agreements.

The snag is, when the market mood turns greedy, a share quickly discounts any prospect of a deal. Bioprogress shares had risen from about 100p to around 160p in anticipation of a second major licensing deal, and at 136.5p from the fall to 107.5p) we are still waiting for news.

It's vital to understand what you're investing in and be disciplined about judging the market price, relative to a sense of the underlying value of the share. This is the touchstone of investing versus speculation. If I can't figure a benchmark value for a share I tend to avoid it, or recognise I'm gambling.

http://tinyurl.com/3amq5

Reply from the said E.Jackson;

I'd always state if I own any share, I write investor diary columns. So if there's no mention I don't own it. This may not be a reflection on the calibre of the share, more my portfolio balance. Right now I'm disinclined to increase overall risk exposure further.

My key point was the eery parallel with 2000 when someone was also chasing me c/o Sunday Telegraph, having bought a big position in an Aim share without a clue what the company did.

At least with Bioprogress there are grounds to think this share could still be a multi-bagger from here, one has to see what evolves and keep re-evaluating. If I was owning Bioprogress shares, I'd keep them tucked away (and respect the risks). Short-term there is lots of excitement already but long-term plenty of potential upside if the company delivers.

Regarding the results presentation, Bioprogress's PR is managed by Bankside Consultants with whom I regularly cross swords because they usually limit the keynote results presentation (as on Photo-Me International) to 'analysts'. I feel this (like at other analyst meetings) is a respectable way to maintain a cartel on insight, for stockbrokers. In my experience of sometimes getting into both 'analyst' and 'press' meetings, there is usually a lot of juicy insight at the analyst meetings that neither companies nor brokers want to see appearing in the press.

But it's also possible to get seduced by an exciting story at these City meets and I've found over the years that shrewd private investors outside the City circles often have a better grasp of the essentials. Investors on this board have identified Bioprogress earlier than the City!